HLS Therapeutics Inc. Opens the Market
16 Marzo 2018 - 9:00AM
PR Newswire (Canada)
TORONTO, March 16, 2018 /CNW/ - Bill Wells, Executive Chairman of the Board, HLS
Therapeutics Inc. (HLS), joined Tim
Babcock, Director, Listed Issuer Services, TSX Venture
Exchange, to open the market. HLS Therapeutics Inc. is a specialty
pharmaceutical company focused on the acquisition and
commercialization of late stage development, commercial stage
promoted and established stage branded pharmaceutical products in
the North American markets. HLS Therapeutics Inc. commenced trading
on TSX Venture Exchange on March 14,
2018.
SOURCE TMX Group Limited
Copyright 2018 Canada NewsWire
Hls Therapeutics (TSXV:HLS)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Hls Therapeutics (TSXV:HLS)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Hls Therapeutics (TSX Venture Exchange): 0 recent articles
Más de TMX Group Limited Artículos de Noticias